Ruifeng Wang
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
Papers in
-
- High-Velocity Impact and Material Behavior 5
-
- Nanoplatforms for cancer theranostics 8
- Co-authors
- Zhiyao Hou (3 shared papers)Jun Lin (4 shared papers)Man Wang (2 shared papers)Mengyu Chang (2 shared papers)Donglian Liu (2 shared papers)Chunzheng Yang (2 shared papers)Tieli Peng (2 shared papers)Chunxia Li (2 shared papers)
- Journals
- Journal of Controlled Release (12 papers)International Journal of Pharmaceutics (7 papers)Chemical Engineering Journal (4 papers)Journal of Materials Research and Technology (3 papers)ACS Applied Materials & Interfaces (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Ruifeng Wang
115 papers receiving 2.4k citations
Ruifeng Wang's Hit Papers
Peers
Comparison fields: 5 of 147
- Biomaterials 450
- Pharmaceutical Science 137
- Biomedical Engineering 852
- Materials Chemistry 901
- Water Science and Technology 153
Countries citing papers authored by Ruifeng Wang
This map shows the geographic impact of Ruifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifeng Wang more than expected).
Fields of papers citing papers by Ruifeng Wang
This network shows the impact of papers produced by Ruifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifeng Wang. The network helps show where Ruifeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruifeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Single‐Atom Pd Nanozyme for Ferroptosis‐Boosted Mild‐Temperature Photothermal Therapy Hit paper breakdown → | 2021 | 620 |
| 2 | 2020 | 85 | |
| 3 | 2021 | 84 | |
| 4 | 2015 | 74 | |
| 5 | 2020 | 67 | |
| 6 | 2019 | 65 | |
| 7 | 2017 | 65 | |
| 8 | 2018 | 53 | |
| 9 | 2019 | 52 | |
| 10 | 2018 | 49 | |
| 11 | 2021 | 45 | |
| 12 | 2019 | 44 | |
| 13 | 2020 | 43 | |
| 14 | 2018 | 41 | |
| 15 | 2021 | 40 | |
| 16 | 2019 | 39 | |
| 17 | 2019 | 37 | |
| 18 | 2019 | 36 | |
| 19 | 2020 | 30 | |
| 20 | 2020 | 28 |
About Ruifeng Wang
Ruifeng Wang is a scholar working on Materials Chemistry, Biomedical Engineering, Molecular Biology, Biomaterials and Mechanical Engineering, having authored 120 papers that have together received 2.5k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (10 papers), Drug Solubulity and Delivery Systems (9 papers), RNA Interference and Gene Delivery (9 papers), Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers), High-Velocity Impact and Material Behavior (5 papers), Chalcogenide Semiconductor Thin Films (5 papers) and biodegradable polymer synthesis and properties (5 papers). The work is most often cited by research in Biomaterials (450 citations), Pharmaceutical Science (137 citations), Biomedical Engineering (852 citations), Materials Chemistry (901 citations) and Water Science and Technology (153 citations). Ruifeng Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zhiyao Hou, Jun Lin, Man Wang, Mengyu Chang, Donglian Liu, Chunzheng Yang, Tieli Peng, Chunxia Li, Li Fang and Weiyue Lu. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Chemical Engineering Journal, Journal of Materials Research and Technology and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.